Alaunos Therapeutics (TCRT) Non-Current Deferred Revenue (2011 - 2018)
Alaunos Therapeutics' Non-Current Deffered Revenue was $49.51 million in Q2 2018, up 29.2% from $38.33 million a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) Non-Current Deferred Revenue (2011 - 2018) Analysis & Trends
At the end of FY2017, Non-Current Deffered Revenue at Alaunos Therapeutics came in at $35.14 million, down 15.4% from FY2016.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 66.7% (FY2012 to FY2017).
- In earlier years, Non-Current Deffered Revenue was $41.53 million in FY2016 (-13.3%), $47.92 million in FY2015 and $1.93 million in FY2013 (-29.3%).
- The Q2 2018 figure marks the highest quarterly Non-Current Deffered Revenue since Q3 2015.
- Compared with a year earlier, Non-Current Deffered Revenue was higher in two of the last eight quarters, with an average decline of 4.1%.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q2 2018 (growth of 29.2%); the worst was Q1 2014 (a decline of 31.6%).
- Per Business Quant data, TCRT's Non-Current Deffered Revenue in the three quarters before Q2 2018 was $49.04 million (Q1 2018), $35.14 million (Q4 2017) and $36.74 million (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Alaunos Therapeutics | 4.16 Mn | 357,198.54 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 49.51 Mn |
| Mar 31, 2018 | 49.04 Mn |
| Dec 31, 2017 | 35.14 Mn |
| Sep 30, 2017 | 36.74 Mn |
| Jun 30, 2017 | 38.33 Mn |
| Mar 31, 2017 | 39.93 Mn |
| Dec 31, 2016 | 41.53 Mn |
| Sep 30, 2016 | 43.13 Mn |
| Jun 30, 2016 | 44.72 Mn |
| Mar 31, 2016 | 46.32 Mn |
| Dec 31, 2015 | 47.92 Mn |
| Sep 30, 2015 | 49.51 Mn |
| Jun 30, 2015 | 816,000.00 |
| Dec 31, 2014 | 1.36 Mn |
| Mar 31, 2014 | 1.73 Mn |
| Dec 31, 2013 | 1.93 Mn |
| Sep 30, 2013 | 2.13 Mn |
| Jun 30, 2013 | 2.33 Mn |
| Mar 31, 2013 | 2.53 Mn |
| Dec 31, 2012 | 2.73 Mn |
API Access
Alaunos Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();